Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-14

Clinical Trial Update: A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Sativex® in relief of spasticity in multiple sclerosis; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Spasticity, Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-14